Model
Edge
Regeneron Pharmaceuticals, Inc.
0001992352
Filing type
144
Filing date
Sep 1, 2026
Updated
Sep 2, 2026 ยท 2:09 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities